The Mushroom Molecule That Supercharges Sleep, Immunity & Performance

The immune benefits of cortisepin tie into its adenosine mimicry. Adenosine receptors exist on immune cells, and activation generally promotes an anti-inflammatory, tissue-protective state. Cortisepin's long half-life makes it a powerful systemic anti-inflammatory. In his practice, Dr. Sher uses it as a first-line supplement for patients with chronic complex medical issues and chronic inflammation, and they do 'fantastically well.' It is also his go-to for travel, along with methylene blue, because airports and airplanes are high-exposure environments. He emphasizes that while cortisepin is powerful, it works best when gut health, hormones, and foundational lifestyle are also addressed. Over time, the goal is to reduce dependency on such compounds by optimizing the underlying systems.

This stack is a creative way to harness the dual nature of cortisepin as an adenosine analog. Adenosine is both a sleep regulator and a metabolic signaling molecule. The brain's response to adenosine is sedation; the periphery's response is often beneficial for energy and blood flow. Dr. Sher notes that caffeine receptors exist in the brain, where the blocking is desired, but caffeine does act elsewhere too. The principle is to temporally steer cortisepin away from the brain. Additionally, if you work out very shortly after taking cortisepin, the increased metabolic demand and blood flow also seem to channel the compound toward energy production, as it forms cortisepin triphosphate (CTP). This approach turns a sleep supplement into a performance enhancer.

The conversation around cortisepin and creatine represents an evolution in sports supplementation, moving from single ingredients to precise molecular synergies. Since cortisepin is an adenosine analog, it can plug directly into the energy pathway. Combined with creatine's phosphate recycling, the stack theoretically provides a two-pronged boost to both immediate and sustained energy. Dr. Sher emphasizes that the key is to avoid the sleepiness side effect; thus, the stack is best implemented with the caffeine strategy or timed right before intense exercise. This protocol is part of a broader philosophy of using AI-modeled combinations to find synergistic pairs, which Troscriptions employs in formulation.

Troches (or troches) are an old compounding pharmacy technology that Dr. Sher has adopted for modern supplements. He chose buccal delivery for several reasons: it enhances bioavailability for poorly absorbed compounds like cortisepin, allows for rapid onset, and offers titratability—users can break a troche into quarters to start low and go slow. Methylene blue, by contrast, is nearly 100% bioavailable whether swallowed or dissolved, but buccal still provides faster onset for those seeking immediate cognitive benefits. The peppermint in the formula prevents the troches from being used rectally, which would otherwise be a viable high-absorption route. The buccal approach also reduces pill fatigue for people already taking many supplements.

Dr. Sher explains that the Cordyceps mushroom is fascinating because it parasitizes insects, taking over their nervous systems. The most active component is cortisepin, an adenosine analog. However, to get meaningful amounts, one would need to eat huge quantities of mushroom. After Dr. Ted Achacoso identified the compound's potential, the team opted for direct synthesis rather than extraction, because extraction from the mushroom was labor-intensive and couldn't scale. By synthesizing it, they produce a cleaner, highly potent molecule that they can formulate into buccal troches at 75 mg and 150 mg strengths. This is the highest cortisepin content of any product on the market. The synthesized molecule is identical to the natural one, just made at scale. This approach represents a marriage of traditional ethnopharmacology and modern pharmaceutical chemistry, enabling consistent, research-backed dosing.

Dr. Sher explains that GABA deficiency is common in people with sleep issues, anxiety, and depression. Their obligate pairing strategy targets two sites on the GABA receptor simultaneously: one molecule binds where GABA itself would bind (the orthosteric site), providing GABAergic tone, while another binds to a separate allosteric site to enhance the affinity for GABA to bind. This ensures the receptor is supported without draining endogenous GABA. The new TroPlusSomna (practitioner-only) uses three ingredients: agurine (from Amanita muscaria, a GABA-mimetic), DHHB (dihydrohonokiol, a highly active magnolia bark compound, positive allosteric modulator), and epigenine (from chamomile, also works on the GABA system as an antioxidant). Dr. Sher contrasts this with their standard Tro sleep formula, which is milder and suitable for those with less severe sleep issues. The obligate pairing is intended to create a comprehensive, safe way to induce sleep without the risk of downregulation.

Dr. Sher describes how Dr. Ted, with an extremely high IQ, has been synthesizing knowledge from various fields, now augmented by AI models that can crunch vast datasets and even design novel compound combinations. They use AI to test formulas in silico before human trials. On the practitioner side, the HOMeP nonprofit offers a 7-module certification, with cohort-based learning that includes metabolomics as a foundational module. The vision is to create a new healthcare system where practitioners, assisted by AI, can optimize patients' health at scale, even potentially handing off some interactions to AI agents while the practitioner is with family. This 'practitioner of the future' concept seeks to break free from systems run by organizations like the American Medical Association, which they see as focused on disease, not health. They hope to see change in 2025 and beyond.

Dr. Sher recommends that unless a person is using cortisepin under close supervision for serious conditions like cancer or autoimmunity, they should consider cycling. He suggests taking it for 2-3 weeks at most, then taking a break, or using it only when needed—such as during travel, when exposed to sick people, or on days with lighter exercise that don't generate enough natural adenosine for good sleep. This approach aligns with the idea of preserving the body's responsiveness and avoiding the downregulation of pathways that can occur with constant stimulation. He frames it as a best practice from clinical experience, noting that when taken too regularly at high doses, 'it doesn't seem to work as well when you do have more of a subjective exposure.'

Dr. Sher explains that cortisepin, or 3-deoxyadenosine, is an adenosine analog that gets incorporated into rapidly dividing cells. Because adenine is a base pair in DNA/RNA, cortisepin can block RNA replication in viruses and tumor cells, triggering apoptosis. He mentions studies in breast, liver, lung, and prostate cancer models. The anti-infective property is especially useful: he used it himself for a year without getting sick, even with four children bringing home illness. The company initially pursued it for sleep but was surprised when cancer studies emerged, causing the ingredient price to rise. While not yet used clinically as a cancer drug in his practice, he notes that related compounds are being investigated as drugs. This positions cortisepin as a molecule with multi-system effects that are only beginning to be understood.